B. Riley analyst Drew Crum raised the firm’s price target on Imax (IMAX) to $46 from $44 and keeps a Buy rating on the shares. Imax reported strong Q4 results, capping a record year with $125.2M revenue driven by a 60%+ increase in C4Q box office and robust system installs, supporting AEBITDA of $57.1M and 45%+ margins, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IMAX: